Trevena

Trevena

Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Founded
2007
Raised
$164M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$45,000,000
Post-IPO equity - 2014
$60,000,000
Venture capital (Series C) - 2013
Forest Laboratories
Team Size
10+
Employees
Pulse 2.0

Trevena (TRVN) Stock: Why The Price Surged Today

the home of AI info

Trevena Inc. (TRVN)'s Financial Results Comparing With Minerva Neurosciences Inc. (NASDAQ ...

The Motley Fool

Here's Why Trevena Stock Dropped 18% Today

The Motley Fool

Why Trevena Inc.'s Shares Broke Through Today

Health Stock markets